AssetMark’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Other funds holding ORIC
SL
AssetMark's ORIC Position: Q3 2026 in Review
AssetMark held its Oric Pharmaceuticals (ORIC) position steady in Q3 2026 at 2,945 shares worth $39.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1971.
AssetMark first reported a position in ORIC in Q3 2025 and has held it in 5 quarters since. 131 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.
- AssetMark held 2,945 shares of Oric Pharmaceuticals worth $39.7K as of Q3 2026.
- AssetMark left its Oric Pharmaceuticals share count unchanged in Q3 2026.
- Oric Pharmaceuticals made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #1971 holding.
- AssetMark first reported a position in Oric Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- 131 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.